Short Interest in Terumo Co. (OTCMKTS:TRUMY) Decreases By 47.4%

Terumo Co. (OTCMKTS:TRUMY - Get Free Report) saw a significant decline in short interest during the month of January. As of January 15th, there was short interest totalling 17,200 shares, a decline of 47.4% from the December 31st total of 32,700 shares. Based on an average daily trading volume, of 133,300 shares, the days-to-cover ratio is presently 0.1 days.

Terumo Stock Performance

Shares of TRUMY traded down $0.12 during mid-day trading on Wednesday, hitting $19.51. The company's stock had a trading volume of 57,249 shares, compared to its average volume of 172,047. The stock's 50-day moving average is $19.61 and its two-hundred day moving average is $18.99. The firm has a market capitalization of $29.08 billion, a PE ratio of 40.76 and a beta of 0.65. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.70 and a current ratio of 2.94. Terumo has a one year low of $14.06 and a one year high of $21.22.

Terumo (OTCMKTS:TRUMY - Get Free Report) last posted its quarterly earnings results on Thursday, November 7th. The company reported $0.13 earnings per share (EPS) for the quarter. The company had revenue of $1.68 billion during the quarter.

Terumo Company Profile

Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.